Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1633752
PUBLISHER: Grand View Research | PRODUCT CODE: 1633752
U.S. Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-center, In-home, SNF-based), By Dialysis (Hemodialysis, Peritoneal Dialysis, Dialysis Chains), By Facility, By Region, And Segment Forecasts, 2025 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
U.S. Dialysis Centers Market Growth & Trends:
The U.S. dialysis centers market size is expected to reach USD 40.39 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.4% from 2025 to 2030. The high prevalence of End-Stage Renal Disease (ESRD) and favorable reimbursement are some of the key factors expected to boost growth. The expenditure on treatment is gradually rising due to the increasing prevalence of ESRD.
The availability of Medicare reimbursement for kidney disorder treatment is increasing the accessibility to the treatment. The Center for Medicare & Medicaid Services announced a new end-stage renal diseases treatment choice model for the maintenance & improvement in the reimbursement for chronic kidney disorder patients. The new model is encouraging the use of home-based treatment. In August 2022, the CMS expanded the eligibility for reimbursement for kidney disorder treatment. The expansion includes certain capital assets, mainly equipment used at home for treatment. This is increasing the accessibility to the services.
The patients need to travel to and fro the center for around 3 days per week, the proximity from the patient's residence is generally an important criterion for the center of choice. Hence the launch of new facilities is a key strategic initiative undertaken by major players to increase their market share. For instance, in May 2021, U.S. Renal Care, Inc. inaugurated three new facilities, one in-center facility and two focusing on home therapies. This expanded the company's presence in the Southwest Florida region.
The COVID-19 pandemic resulted in patients facing difficulty in having an access to treatment for end-stage renal disorder, requiring multiple sessions within a month. According to the national kidney foundation, 15.8% of the patients undergoing treatment for end-stage renal disease had COVID-19 infection. The federal government & service providers promoted home treatment. In June 2021, a new campaign innovative kidney care was launched by nine leading healthcare organizations for patient options for receiving home treatment.
U.S. Dialysis Centers Market Report Highlights:
- Based on service, the in-center segment held the largest revenue share in 2024. This can be attributed to the need for assistance & care for the procedure, which can be facilitated better at the centers. The high preference for hemodialysis is also driving the market opportunity as it essentially requires center visits & assistance.
- Based on dialysis type, hemodialysis dominated the market in 2024. This can be attributed to the preference for the segment by healthcare professionals & longer life expectancy for patients. However peritoneal dialysis is expected to have the fastest growth during the forecast period owing to the effective removal of toxic substances & high convenience of peritoneal dialysis enabling patients to independently have treatment at home.
- Based on facility type, dialysis chains dominated the market in 2024. This can be attributed to the presence of such chains throughout the U.S. The availability of top-quality equipment and treatment at a lower cost compared to hospital-based facilities is driving the segment's growth. In addition, the key players are acquiring independent facilities, resulting in most of the independent facilities being managed by chains.
- The service providers and patients faced challenges since the onset of the COVID-19 pandemic, some of which are unique as compared to other health facilities and treatment groups. For instance, hemodialysis (HD) patients visit centers at least three times a week and during each session, the patients are exposed to all the patients concurrently receiving treatment in a particular session, and to healthcare personnel along with any additional exposure during their travel to and from the center.
- Mergers & acquisitions and collaborations are being preferred by the key players, enabling them to have a competitive edge by adding value to their services. For Instance, in March 2022, Fresenius Medical Care announced a merger with InterWell Health and Cricket Health for facilitating better kidney disorder solutions.
Product Code: GVR-4-68039-990-8
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Modality
- 1.2.2. Dialysis
- 1.2.3. Facility
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Dialysis Centers Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
Chapter 4. U.S. Dialysis Centers Market: Modality Business Analysis
- 4.1. Modality Market Share, 2024 & 2030
- 4.2. Modality Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Modality, 2018 to 2030 (USD Million)
- 4.4. In-center
- 4.4.1. In-center Market, 2018 - 2030 (USD Million)
- 4.5. In-home
- 4.5.1. In-home Market, 2018 - 2030 (USD Million)
- 4.6. SNF-based
- 4.6.1. SNF-based Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Dialysis Centers Market: Dialysis Business Analysis
- 5.1. Dialysis Market Share, 2024 & 2030
- 5.2. Dialysis Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Dialysis, 2018 to 2030 (USD Million)
- 5.4. Hemodialysis
- 5.4.1. Hemodialysis Market, 2018 - 2030 (USD Million)
- 5.5. Peritoneal Dialysis
- 5.5.1. Peritoneal Dialysis Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Dialysis Centers Market: Facility Business Analysis
- 6.1. Facility Market Share, 2024 & 2030
- 6.2. Facility Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by Facility, 2018 to 2030 (USD Million)
- 6.4. Dialysis Chains
- 6.4.1. Dialysis Chains Market, 2018 - 2030 (USD Million)
- 6.5. Independent Facilities
- 6.5.1. Independent Facilities Market, 2018 - 2030 (USD Million)
- 6.6. Hospital-based
- 6.6.1. Hospital-based Market, 2018 - 2030 (USD Million)
Chapter 7. U.S. Dialysis Centers Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.4. West
- 7.4.1. West U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5. Midwest
- 7.5.1. Midwest U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6. Northeast
- 7.6.1. Northeast U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7. Southeast
- 7.7.1. Southeast U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8. Southwest
- 7.8.1. Southwest U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Overview
- 8.2. Company Market Position Analysis
- 8.3. Company Categorization
- 8.4. Strategy Mapping
- 8.5. Company Profiles/Listing
- 8.5.1. Fresenius Medical Care AG
- 8.5.1.1. Overview
- 8.5.1.2. Financial Performance
- 8.5.1.3. Product Benchmarking
- 8.5.1.4. Strategic Initiatives
- 8.5.2. U.S. Renal Care, Inc.
- 8.5.2.1. Overview
- 8.5.2.2. Financial Performance
- 8.5.2.3. Product Benchmarking
- 8.5.2.4. Strategic Initiatives
- 8.5.3. DaVita Inc.
- 8.5.3.1. Overview
- 8.5.3.2. Financial Performance
- 8.5.3.3. Product Benchmarking
- 8.5.3.4. Strategic Initiatives
- 8.5.4. Innovative Renal Care
- 8.5.4.1. Overview
- 8.5.4.2. Financial Performance
- 8.5.4.3. Product Benchmarking
- 8.5.4.4. Strategic Initiatives
- 8.5.5. DCI
- 8.5.5.1. Overview
- 8.5.5.2. Financial Performance
- 8.5.5.3. Product Benchmarking
- 8.5.5.4. Strategic Initiatives
- 8.5.6. SATELLITE HEALTHCARE
- 8.5.6.1. Overview
- 8.5.6.2. Financial Performance
- 8.5.6.3. Product Benchmarking
- 8.5.6.4. Strategic Initiatives
- 8.5.7. Northwest Kidney Centers
- 8.5.7.1. Overview
- 8.5.7.2. Financial Performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic Initiatives
- 8.5.8. Centers for Dialysis Care
- 8.5.8.1. Overview
- 8.5.8.2. Financial Performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic Initiatives
- 8.5.9. Rogosin Institute
- 8.5.9.1. Overview
- 8.5.9.2. Financial Performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic Initiatives
- 8.5.10. Dialysis Care Center
- 8.5.10.1. Overview
- 8.5.10.2. Financial Performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic Initiatives
- 8.5.11. USCF Health (The Regents of The University of California)
- 8.5.11.1. Overview
- 8.5.11.2. Financial Performance
- 8.5.11.3. Product Benchmarking
- 8.5.11.4. Strategic Initiatives
- 8.5.12. Rhode Island Hospital, Department of Health Rhode Island
- 8.5.12.1. Overview
- 8.5.12.2. Financial Performance
- 8.5.12.3. Product Benchmarking
- 8.5.12.4. Strategic Initiatives
- 8.5.13. University of Iowa Hospital & Clinics
- 8.5.13.1. Overview
- 8.5.13.2. Financial Performance
- 8.5.13.3. Product Benchmarking
- 8.5.13.4. Strategic Initiatives
- 8.5.14. Saint Anthony Hospital
- 8.5.14.1. Overview
- 8.5.14.2. Financial Performance
- 8.5.14.3. Product Benchmarking
- 8.5.14.4. Strategic Initiatives
- 8.5.15. Rush University Children's Hospital
- 8.5.15.1. Overview
- 8.5.15.2. Financial Performance
- 8.5.15.3. Product Benchmarking
- 8.5.15.4. Strategic Initiatives
- 8.5.1. Fresenius Medical Care AG
Product Code: GVR-4-68039-990-8
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 U.S. dialysis centers market, by modality, 2018 - 2030 (USD Million)
- Table 4 U.S. dialysis centers market, by dialysis, 2018 - 2030 (USD Million)
- Table 5 U.S. dialysis centers market, by facility, 2018 - 2030 (USD Million)
- Table 6 U.S. dialysis centers market, by region, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 U.S. dialysis centers market segmentation
- Fig. 2 Market research process
- Fig. 3 Data triangulation techniques
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 Market formulation & validation
- Fig. 8 Market snapshot
- Fig. 9 Modality and dialysis outlook (USD Million)
- Fig. 10 Facility outlook (USD Million)
- Fig. 11 Competitive landscape
- Fig. 12 U.S. dialysis centers market dynamics
- Fig. 13 U.S. dialysis centers market: Porter's five forces analysis
- Fig. 14 U.S. dialysis centers market: PESTLE analysis
- Fig. 15 U.S. dialysis centers market: Modality segment dashboard
- Fig. 16 U.S. dialysis centers market: Modality market share analysis, 2024 & 2030
- Fig. 17 In-center market, 2018 - 2030 (USD Million)
- Fig. 18 In-home market, 2018 - 2030 (USD Million)
- Fig. 19 SNF-based market, 2018 - 2030 (USD Million)
- Fig. 20 U.S. dialysis centers market: Dialysis segment dashboard
- Fig. 21 U.S. dialysis centers market: Dialysis market share analysis, 2024 & 2030
- Fig. 22 Hemodialysis market, 2018 - 2030 (USD Million)
- Fig. 23 Peritoneal dialysis market, 2018 - 2030 (USD Million)
- Fig. 24 U.S. dialysis centers market: Facility segment dashboard
- Fig. 25 U.S. dialysis centers market: Facility market share analysis, 2024 & 2030
- Fig. 26 Dialysis chains market, 2018 - 2030 (USD Million)
- Fig. 27 Independent facilities market, 2018 - 2030 (USD Million)
- Fig. 28 Hospital-based market, 2018 - 2030 (USD Million)
- Fig. 29 U.S. dialysis centers market revenue, by region
- Fig. 30 Regional marketplace: Key takeaways
- Fig. 31 Regional marketplace: Key takeaways
- Fig. 32 West U.S. dialysis centers market, 2018 - 2030 (USD Million)
- Fig. 33 Midwest U.S. dialysis centers market, 2018 - 2030 (USD Million)
- Fig. 34 Northeast U.S. dialysis centers market, 2018 - 2030 (USD Million)
- Fig. 35 Southeast U.S. dialysis centers market, 2018 - 2030 (USD Million)
- Fig. 36 Southwest U.S. dialysis centers market, 2018 - 2030 (USD Million)
- Fig. 37 Company categorization
- Fig. 38 Company market position analysis
- Fig. 39 Strategic framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.